<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04633057</url>
  </required_header>
  <id_info>
    <org_study_id>CTJ101PGHD301</org_study_id>
    <nct_id>NCT04633057</nct_id>
  </id_info>
  <brief_title>A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency</brief_title>
  <official_title>A Phase III, Randomized, Open-label, Positive-controlled, Multi-center Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>I-Mab Biopharma Co. Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>I-Mab Biopharma Co. Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Phase III, Randomized, open-label, positive-drug parallel control, Study to Evaluate the&#xD;
      Efficacy and Safety of TJ101 in Child subject with growth hormone deficieney.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Annualized Height velocity at 52 week</measure>
    <time_frame>52weeks after first dose</time_frame>
    <description>The Annualized Height velocity at 52 week</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in Annualized Height velocity at 26 week (compared to Baseline value)</measure>
    <time_frame>26weeks after first dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in Annualized Height velocity at 52 week (compared to Baseline value)</measure>
    <time_frame>52weeks after first dose</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">165</enrollment>
  <condition>Pediatric Growth Hormone Deficiency</condition>
  <arm_group>
    <arm_group_label>TJ101</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TJ101 1.2 mg/kg once a week for 52weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NordiFlex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NordiFlex Injection 0.034 mg/kg once a day for 52 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TJ101</intervention_name>
    <description>TJ101/ Recombinant Human Somatropin Injection treatment: after screening, subjects will be randomized to receive TJ101 1.2 mg/kg once a week until 52 weeks back site, investigator evaluate effectiveness and safety.</description>
    <arm_group_label>TJ101</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NordiFlex</intervention_name>
    <description>TJ101/ Recombinant Human Somatropin Injection treatment: after screening, subjects will be randomized to receive Recombinant Human Somatropin Injection 0.034 mg/kg once a day, until 52 weeks back site, investigator evaluate effectiveness and safety.</description>
    <arm_group_label>NordiFlex</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Boys: 3 years ≤ boy's age ≤ 10 years；Girls: 3 years ≤ girl's age ≤ 9 years&#xD;
&#xD;
          2. Pre-pubertal children(Tanner stage I)&#xD;
&#xD;
          3. GHD confirmed by 2 different GH provocation tests with peak GH concentration below 10&#xD;
             ng/mL in screening or one month&#xD;
&#xD;
          4. Height (HT) of at least 2.0 standard deviations (SD) below the mean height for&#xD;
             chronological age (CA) and gender according to Table of standard deviation unit values&#xD;
             of age and height of Chinese children aged 3-12 years , (HT SDS ≤ -2.0)&#xD;
&#xD;
          5. Height velocity≤5.0cm/years (Including height records before at least three months)；&#xD;
&#xD;
          6. IGF-1 SDS≤-1.0&#xD;
&#xD;
          7. Bone age (BA) is no more than two chronological age&#xD;
&#xD;
          8. Body mass Index (BMI) must be within ±2 SD of mean BMI for the chronological age and&#xD;
             sex according to Table of standard deviation unit values of Age and BMI of Chinese&#xD;
             children aged 3-12 years&#xD;
&#xD;
          9. Without prior exposure to any rhGH therapy&#xD;
&#xD;
         10. For children with growth hormone deficiency that is one of its multiple pituitary&#xD;
             hormone deficiencies, alternative therapies targeting the&#xD;
             hypothalamus-pituitary-target gland axis must be used for at least 3 months before&#xD;
             screening&#xD;
&#xD;
         11. Written informed consent of the parent or legal guardian of the subject and assent of&#xD;
             the subject (if the subject can read)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. beyond physiological dosage of glucocorticoid therapy&#xD;
&#xD;
          2. Evidence of closed epiphyses&#xD;
&#xD;
          3. Any other chronic condition that can cause short stature and cannot be treated with&#xD;
             hormone replacement therapy(Including but not limited Chronic kidney disease,&#xD;
             malnutrition, absorption disorders, uncontrolled hypothyroidism, celiac disease,&#xD;
             rickets and social-psychological dwarfism)&#xD;
&#xD;
          4. Abnormal liver and renal function (ALT&gt;1.5 times the upper limit of normal range and&#xD;
             Cr exceeding the upper limit of normal range)&#xD;
&#xD;
          5. Presence of anti-hGH antibodies at screening&#xD;
&#xD;
          6. Concomitant administration of other treatments that may have an effect on growth such&#xD;
             as anabolic steroids, with the exception of ADHD(attention deficit hyperactivity&#xD;
             disorder) drug hormone replacement therapies [thyroxine, hydrocortisone, desmopressin&#xD;
             (DDAVP)]&#xD;
&#xD;
          7. Mutations in growth hormone receptors are suspected, or any syndrome that causes&#xD;
             insensitivity to growth hormone&#xD;
&#xD;
          8. At screening, ophthalmologic examination (including fundus microscopy) indicated&#xD;
             increased intracranial pressure and/or retinopathy.&#xD;
&#xD;
          9. At screening, previous or existing intracranial tumor growth was confirmed by cranial&#xD;
             magnetic resonance imaging (MRI) scan (using contrast agent) (MRI results up to 1 year&#xD;
             prior to screening were acceptable)&#xD;
&#xD;
         10. Diseases such as severe cardiopulmonary, blood system, malignant tumor or potential&#xD;
             tumor (family history), or systemic infection, low immune function and mental diseases&#xD;
&#xD;
         11. Significant spinal abnormalities, including scoliosis (Cobb Angle &amp; GT;60 ˚), kyphosis&#xD;
             and spina bifida.&#xD;
&#xD;
         12. Subjects diagnosed with type 2 or type 1 diabetes who were considered to have received&#xD;
             no standard treatment, did not follow their prescribed treatment, or exhibited poor&#xD;
             metabolic control, or had fasting glucose &gt; 5.6 mmol/L twice in a row&#xD;
&#xD;
         13. Chromosomal abnormalities and medical syndromes (Turner's syndrome, Laron syndrome,&#xD;
             Noonan syndrome, Prader-Willi syndrome, Russell-Silver Syndrome, SHOX&#xD;
             mutations/deletions and skeletal dysplasias), with the exception of septo-optic&#xD;
             dysplasia&#xD;
&#xD;
         14. Children with low birth weight (birth weight and/or body length are 2 SD below average&#xD;
             according to the standard of the general Chinese population of the same gestational&#xD;
             age and sex)&#xD;
&#xD;
         15. The subject and/or the parent/legal guardian are likely to be non-compliant in respect&#xD;
             to study conduct&#xD;
&#xD;
         16. Subject who has received an investigational product or has participated in a clinical&#xD;
             study within 30 days before screening or during the clinical trials.&#xD;
&#xD;
         17. Known or suspected to be HIV positive, serologically positive for syphilis, or other&#xD;
             chronic infectious diseases, such as AIDS, tuberculosis, hepatitis, etc&#xD;
&#xD;
         18. The history of drug, drug or alcohol abuse&#xD;
&#xD;
         19. Other conditions not considered suitable for inclusion by the researchers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xiaoping Luo</last_name>
    <phone>13387522645</phone>
    <email>xpluo@sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wei Wu</last_name>
    <phone>13871186026</phone>
    <email>wuweir11@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Second Affiliated Hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deyun Liu, Master</last_name>
      <phone>13966699361</phone>
      <email>1355168128@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Children's Hospital,Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chunxiu Gong, Doctor</last_name>
      <phone>13370115001</phone>
      <email>chunxiugong@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital, Capital Institute of Paediatrics</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaobo Chen, Doctor</last_name>
      <phone>136 8109 4823</phone>
      <email>xiaobochen6362@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chongqing Three Gorges Central Hospital</name>
      <address>
        <city>Wanzhou</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Luo, Doctor</last_name>
      <phone>13594761986</phone>
      <email>yuyuanlyy@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sun Yat-sen Memorial Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liyang Liang, Doctor</last_name>
      <phone>136 8889 1219</phone>
      <email>doclly@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Sun Yet-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shunye Zhu, Doctor</last_name>
      <phone>13560315814</phone>
      <email>13560315814@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liuzhou Maternity and Children Healthcare Hospital</name>
      <address>
        <city>Liuzhou</city>
        <state>Guangxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ting Zeng, Master</last_name>
      <phone>13978077499</phone>
      <email>zengting2008@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hainan Third People's Hospital</name>
      <address>
        <city>Sanya</city>
        <state>Hainan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua Zhang, Doctor</last_name>
      <phone>13876581288</phone>
      <email>1271237158@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tangshan Women and Children's Hospital</name>
      <address>
        <city>Tangshan</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lanying Wang, Master</last_name>
      <phone>13932537139</phone>
      <email>1299149713@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henan Children's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haiyan Wei, Doctor</last_name>
      <phone>13838501183</phone>
      <email>haiyanwei2009@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoping Luo</last_name>
      <phone>13387522645</phone>
      <email>xpluo@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Wei Wu</last_name>
      <phone>13871186026</phone>
      <email>wuweir11@163.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Wuhan Children's Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hui Yao, Doctor</last_name>
      <phone>15807177810</phone>
      <email>yaohui1024@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hunan Children's Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yan Zhong, Doctor</last_name>
      <phone>17377789580</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Nanhua University</name>
      <address>
        <city>Hengyang</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinhua Xiao, Doctor</last_name>
      <phone>13974703153</phone>
      <email>xiaoxinhua139@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wei Gu, Doctor</last_name>
      <phone>18951769571</phone>
      <email>guwei154@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jiangsu Provincial Maternal and Child Health Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lan Ling, Master</last_name>
      <phone>13851622200</phone>
      <email>linglan0420@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital affiliated to Soochow University</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ting Chen, Master</last_name>
      <phone>18012619649</phone>
      <email>chenting888@suda.edu.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jiangxi Provincial Children's Hospital</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Yang, Doctor</last_name>
      <phone>13870982952</phone>
      <email>yangyu5168@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pingxiang Maternity and Child Care Hospital</name>
      <address>
        <city>Pingxiang</city>
        <state>Jiangxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Li Zhou</last_name>
      <phone>13879984080</phone>
      <email>675110277@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Bethune Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yining Zhang, Doctor</last_name>
      <phone>15043091102</phone>
      <email>yining@jlu.edu.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ying Xin, Bachelor</last_name>
      <phone>18940251876</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Hospital of Ningxia Medical University</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jinhai Ma, Doctor</last_name>
      <phone>13995306967</phone>
      <email>markhcn@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Jining Medical College</name>
      <address>
        <city>Jining</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mei Zhang, Master</last_name>
      <phone>18678766682</phone>
      <email>13515374089@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Linyi Women and Children's Hospital</name>
      <address>
        <city>Linyi</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiuying Ge, Bachelor</last_name>
      <phone>13869961868</phone>
      <email>gexiuying1964@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Children's Medical Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiumin Wang, Doctor</last_name>
      <phone>18017395221</phone>
      <email>wangxiumin1019@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Jiaotong University School of Medicine Ruijin Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhiya Dong, Master</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chengdu Women's and Children's Central Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinran Cheng, Master</last_name>
      <phone>18980867956</phone>
      <email>cxr1216@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West China Second Hospital of Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fan Yang, Doctor</last_name>
      <phone>18180609105</phone>
      <email>506742295@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Taizhou First People's Hospital</name>
      <address>
        <city>Liuzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoming Ying, Master</last_name>
      <phone>15105868306</phone>
      <email>yxm2306@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ningbo Women &amp; Children's Hospital</name>
      <address>
        <city>Ningbo</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shuxia Ding, Bachelor</last_name>
      <phone>13454712767</phone>
      <email>dingsx75@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>November 12, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>July 5, 2021</last_update_submitted>
  <last_update_submitted_qc>July 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dwarfism, Pituitary</mesh_term>
    <mesh_term>Endocrine System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

